The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Leukapheresis-Global Market Insights and Sales Trends 2025
Synopsis
Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. It is a specific type of apheresis, the more general term for separating out one particular constituent of blood and returning the remainder to the circulation.
The global Leukapheresis market size is expected to reach US$ 92 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Leukapheresis in various end use industries. The expanding demands from the Hospitals and Research Institute, are propelling Leukapheresis market. Leukapheresis Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Leukapheresis Disposables segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Leukapheresis market, driven by demand from China, the second largest economy with some signs of stabilising, the Leukapheresis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Leukapheresis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Leukapheresis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Leukapheresis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Leukapheresis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Leukapheresis covered in this report include Asahi Kasei Medical, Fresenius, Haemonetics, Hemacare Corporation, Terumo BCT, Stemcell Technologies and Bioivt, etc.
The global Leukapheresis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Asahi Kasei Medical
Fresenius
Haemonetics
Hemacare Corporation
Terumo BCT
Stemcell Technologies
Bioivt
Global Leukapheresis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Leukapheresis market, Segment by Type:
Leukapheresis Devices
Leukapheresis Disposables
Global Leukapheresis market, by Application
Hospitals
Research Institute
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Leukapheresis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Leukapheresis is a laboratory procedure in which white blood cells are separated from a sample of blood. It is a specific type of apheresis, the more general term for separating out one particular constituent of blood and returning the remainder to the circulation.
The global Leukapheresis market size is expected to reach US$ 92 million by 2029, growing at a CAGR of 6.2% from 2023 to 2029. The market is mainly driven by the significant applications of Leukapheresis in various end use industries. The expanding demands from the Hospitals and Research Institute, are propelling Leukapheresis market. Leukapheresis Devices, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Leukapheresis Disposables segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Leukapheresis market, driven by demand from China, the second largest economy with some signs of stabilising, the Leukapheresis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Leukapheresis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Leukapheresis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Leukapheresis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Leukapheresis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Leukapheresis covered in this report include Asahi Kasei Medical, Fresenius, Haemonetics, Hemacare Corporation, Terumo BCT, Stemcell Technologies and Bioivt, etc.
The global Leukapheresis market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Asahi Kasei Medical
Fresenius
Haemonetics
Hemacare Corporation
Terumo BCT
Stemcell Technologies
Bioivt
Global Leukapheresis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Leukapheresis market, Segment by Type:
Leukapheresis Devices
Leukapheresis Disposables
Global Leukapheresis market, by Application
Hospitals
Research Institute
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Leukapheresis companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Leukapheresis
1.1 Leukapheresis Market Overview
1.1.1 Leukapheresis Product Scope
1.1.2 Leukapheresis Market Status and Outlook
1.2 Global Leukapheresis Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Leukapheresis Market Size by Region (2018-2029)
1.4 Global Leukapheresis Historic Market Size by Region (2018-2023)
1.5 Global Leukapheresis Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Leukapheresis Market Size (2018-2029)
1.6.1 North America Leukapheresis Market Size (2018-2029)
1.6.2 Europe Leukapheresis Market Size (2018-2029)
1.6.3 Asia-Pacific Leukapheresis Market Size (2018-2029)
1.6.4 Latin America Leukapheresis Market Size (2018-2029)
1.6.5 Middle East & Africa Leukapheresis Market Size (2018-2029)
2 Leukapheresis Market by Type
2.1 Introduction
2.1.1 Leukapheresis Devices
2.1.2 Leukapheresis Disposables
2.2 Global Leukapheresis Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Leukapheresis Historic Market Size by Type (2018-2023)
2.2.2 Global Leukapheresis Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Leukapheresis Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Leukapheresis Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Leukapheresis Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Leukapheresis Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Leukapheresis Revenue Breakdown by Type (2018-2029)
3 Leukapheresis Market Overview by Application
3.1 Introduction
3.1.1 Hospitals
3.1.2 Research Institute
3.2 Global Leukapheresis Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Leukapheresis Historic Market Size by Application (2018-2023)
3.2.2 Global Leukapheresis Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Leukapheresis Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Leukapheresis Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Leukapheresis Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Leukapheresis Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Leukapheresis Revenue Breakdown by Application (2018-2029)
4 Leukapheresis Competition Analysis by Players
4.1 Global Leukapheresis Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Leukapheresis as of 2022)
4.3 Date of Key Players Enter into Leukapheresis Market
4.4 Global Top Players Leukapheresis Headquarters and Area Served
4.5 Key Players Leukapheresis Product Solution and Service
4.6 Competitive Status
4.6.1 Leukapheresis Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Asahi Kasei Medical
5.1.1 Asahi Kasei Medical Profile
5.1.2 Asahi Kasei Medical Main Business
5.1.3 Asahi Kasei Medical Leukapheresis Products, Services and Solutions
5.1.4 Asahi Kasei Medical Leukapheresis Revenue (US$ Million) & (2018-2023)
5.1.5 Asahi Kasei Medical Recent Developments
5.2 Fresenius
5.2.1 Fresenius Profile
5.2.2 Fresenius Main Business
5.2.3 Fresenius Leukapheresis Products, Services and Solutions
5.2.4 Fresenius Leukapheresis Revenue (US$ Million) & (2018-2023)
5.2.5 Fresenius Recent Developments
5.3 Haemonetics
5.3.1 Haemonetics Profile
5.3.2 Haemonetics Main Business
5.3.3 Haemonetics Leukapheresis Products, Services and Solutions
5.3.4 Haemonetics Leukapheresis Revenue (US$ Million) & (2018-2023)
5.3.5 Hemacare Corporation Recent Developments
5.4 Hemacare Corporation
5.4.1 Hemacare Corporation Profile
5.4.2 Hemacare Corporation Main Business
5.4.3 Hemacare Corporation Leukapheresis Products, Services and Solutions
5.4.4 Hemacare Corporation Leukapheresis Revenue (US$ Million) & (2018-2023)
5.4.5 Hemacare Corporation Recent Developments
5.5 Terumo BCT
5.5.1 Terumo BCT Profile
5.5.2 Terumo BCT Main Business
5.5.3 Terumo BCT Leukapheresis Products, Services and Solutions
5.5.4 Terumo BCT Leukapheresis Revenue (US$ Million) & (2018-2023)
5.5.5 Terumo BCT Recent Developments
5.6 Stemcell Technologies
5.6.1 Stemcell Technologies Profile
5.6.2 Stemcell Technologies Main Business
5.6.3 Stemcell Technologies Leukapheresis Products, Services and Solutions
5.6.4 Stemcell Technologies Leukapheresis Revenue (US$ Million) & (2018-2023)
5.6.5 Stemcell Technologies Recent Developments
5.7 Bioivt
5.7.1 Bioivt Profile
5.7.2 Bioivt Main Business
5.7.3 Bioivt Leukapheresis Products, Services and Solutions
5.7.4 Bioivt Leukapheresis Revenue (US$ Million) & (2018-2023)
5.7.5 Bioivt Recent Developments
6 North America
6.1 North America Leukapheresis Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Leukapheresis Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Leukapheresis Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Leukapheresis Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Leukapheresis Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Leukapheresis Market Dynamics
11.1 Leukapheresis Industry Trends
11.2 Leukapheresis Market Drivers
11.3 Leukapheresis Market Challenges
11.4 Leukapheresis Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
